The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
92396027 9239602 7 F 2002 20160805 20130418 20160810 EXP US-009507513-1304USA008275 MERCK 0.00 M Y 86.35000 KG 20160810 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
92396027 9239602 1 PS PROPECIA FINASTERIDE 1 Oral 1 MG, QD U 20788 1 MG FILM-COATED TABLET QD
92396027 9239602 2 SS PROPECIA FINASTERIDE 1 U 20788 FILM-COATED TABLET
92396027 9239602 3 SS FINASTERIDE. FINASTERIDE 1 Oral 1 MG, UNK 0 1 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
92396027 9239602 1 Alopecia
92396027 9239602 2 Androgenetic alopecia
92396027 9239602 3 Androgenetic alopecia

Outcome of event

Event ID CASEID OUTC COD
92396027 9239602 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
92396027 9239602 Abdominal pain
92396027 9239602 Abnormal loss of weight
92396027 9239602 Adverse event
92396027 9239602 Anxiety
92396027 9239602 Blood iron increased
92396027 9239602 Blood testosterone decreased
92396027 9239602 Cataract
92396027 9239602 Chest pain
92396027 9239602 Chromaturia
92396027 9239602 Chronic obstructive pulmonary disease
92396027 9239602 Cognitive disorder
92396027 9239602 Decreased appetite
92396027 9239602 Decreased interest
92396027 9239602 Depression
92396027 9239602 Erectile dysfunction
92396027 9239602 Fatigue
92396027 9239602 Flushing
92396027 9239602 Gastrooesophageal reflux disease
92396027 9239602 Haemochromatosis
92396027 9239602 Headache
92396027 9239602 Hypercholesterolaemia
92396027 9239602 Hypertensive heart disease
92396027 9239602 Insomnia
92396027 9239602 Libido decreased
92396027 9239602 Lipoma
92396027 9239602 Mycobacterium tuberculosis complex test positive
92396027 9239602 Pain in extremity
92396027 9239602 Paraesthesia
92396027 9239602 Polycythaemia
92396027 9239602 Rotator cuff syndrome
92396027 9239602 Sexual dysfunction
92396027 9239602 Shoulder operation
92396027 9239602 Spinal pain
92396027 9239602 Tendonitis
92396027 9239602 Urinary tract disorder
92396027 9239602 Vision blurred
92396027 9239602 Visual impairment
92396027 9239602 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
92396027 9239602 1 1999 20140825 0
92396027 9239602 3 20130210 20160714 0